Back to Journals » Cancer Management and Research » Volume 7

Ipilimumab was safe and effective in two patients with metastatic melanoma and end-stage renal disease

Authors Cavalcante L, Amin A, Lutzky J

Received 28 August 2014

Accepted for publication 22 October 2014

Published 19 January 2015 Volume 2015:7 Pages 47—50

DOI https://doi.org/10.2147/CMAR.S73389

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 4

Editor who approved publication: Professor Kenan Onel

Ludimila Cavalcante,1 Asim Amin,2 Jose Lutzky1

1Department of Hematology and Oncology, Mount Sinai Medical Center, Miami Beach, FL, USA; 2Levine Cancer Institute, Charlotte, NC, USA

Abstract: This is a unique report of two cases of patients with end-stage renal disease on hemodialysis, receiving ipilimumab for treatment of metastatic melanoma, as there is a paucity of safety and efficacy data in this patient subgroup.

Keywords: report of cases, hemodialysis, advanced melanoma


Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]